vs

Side-by-side financial comparison of Hippo Holdings Inc. (HIPO) and Inogen Inc (INGN). Click either name above to swap in a different company.

Hippo Holdings Inc. is the larger business by last-quarter revenue ($120.4M vs $68.6M, roughly 1.8× Inogen Inc). On growth, Hippo Holdings Inc. posted the faster year-over-year revenue change (18.2% vs 3.4%). Hippo Holdings Inc. produced more free cash flow last quarter ($9.1M vs $-1.9M). Over the past eight quarters, Hippo Holdings Inc.'s revenue compounded faster (18.9% CAGR vs 4.2%).

Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

HIPO vs INGN — Head-to-Head

Bigger by revenue
HIPO
HIPO
1.8× larger
HIPO
$120.4M
$68.6M
INGN
Growing faster (revenue YoY)
HIPO
HIPO
+14.7% gap
HIPO
18.2%
3.4%
INGN
More free cash flow
HIPO
HIPO
$11.0M more FCF
HIPO
$9.1M
$-1.9M
INGN
Faster 2-yr revenue CAGR
HIPO
HIPO
Annualised
HIPO
18.9%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIPO
HIPO
INGN
INGN
Revenue
$120.4M
$68.6M
Net Profit
$6.0M
Gross Margin
51.4%
Operating Margin
5.6%
-13.6%
Net Margin
5.0%
Revenue YoY
18.2%
3.4%
Net Profit YoY
-86.4%
EPS (diluted)
$0.31
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIPO
HIPO
INGN
INGN
Q4 25
$120.4M
$68.6M
Q3 25
$120.6M
$79.1M
Q2 25
$117.3M
$79.2M
Q1 25
$110.3M
$68.5M
Q4 24
$101.9M
$66.3M
Q3 24
$95.5M
$74.9M
Q2 24
$89.6M
$74.4M
Q1 24
$85.1M
$63.1M
Net Profit
HIPO
HIPO
INGN
INGN
Q4 25
$6.0M
Q3 25
$98.1M
$-5.3M
Q2 25
$1.3M
$-4.2M
Q1 25
$-47.7M
$-6.2M
Q4 24
$44.2M
Q3 24
$-8.5M
$-6.0M
Q2 24
$-40.5M
$-5.6M
Q1 24
$-35.7M
$-14.6M
Gross Margin
HIPO
HIPO
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
HIPO
HIPO
INGN
INGN
Q4 25
5.6%
-13.6%
Q3 25
81.3%
-9.0%
Q2 25
3.4%
-7.7%
Q1 25
-41.3%
-11.2%
Q4 24
46.3%
-17.2%
Q3 24
-5.4%
-10.4%
Q2 24
-40.7%
-9.5%
Q1 24
-38.7%
-25.8%
Net Margin
HIPO
HIPO
INGN
INGN
Q4 25
5.0%
Q3 25
81.3%
-6.7%
Q2 25
1.1%
-5.2%
Q1 25
-43.2%
-9.0%
Q4 24
43.4%
Q3 24
-8.9%
-8.0%
Q2 24
-45.2%
-7.5%
Q1 24
-42.0%
-23.1%
EPS (diluted)
HIPO
HIPO
INGN
INGN
Q4 25
$0.31
$-0.26
Q3 25
$3.77
$-0.20
Q2 25
$0.05
$-0.15
Q1 25
$-1.91
$-0.25
Q4 24
$1.81
$-0.41
Q3 24
$-0.34
$-0.25
Q2 24
$-1.64
$-0.24
Q1 24
$-1.47
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIPO
HIPO
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$218.3M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$436.1M
$192.2M
Total Assets
$1.9B
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIPO
HIPO
INGN
INGN
Q4 25
$218.3M
$103.7M
Q3 25
$247.7M
$106.5M
Q2 25
$198.9M
$103.7M
Q1 25
$140.9M
$118.9M
Q4 24
$197.6M
$113.8M
Q3 24
$191.2M
$105.7M
Q2 24
$175.9M
$97.9M
Q1 24
$223.4M
$107.4M
Stockholders' Equity
HIPO
HIPO
INGN
INGN
Q4 25
$436.1M
$192.2M
Q3 25
$421.5M
$197.2M
Q2 25
$332.5M
$199.5M
Q1 25
$322.8M
$198.0M
Q4 24
$362.1M
$173.9M
Q3 24
$326.4M
$185.4M
Q2 24
$322.6M
$187.6M
Q1 24
$351.2M
$191.9M
Total Assets
HIPO
HIPO
INGN
INGN
Q4 25
$1.9B
$298.6M
Q3 25
$1.9B
$307.0M
Q2 25
$1.7B
$312.0M
Q1 25
$1.5B
$308.4M
Q4 24
$1.5B
$296.2M
Q3 24
$1.5B
$306.2M
Q2 24
$1.5B
$308.9M
Q1 24
$1.5B
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIPO
HIPO
INGN
INGN
Operating Cash FlowLast quarter
$9.2M
$-943.0K
Free Cash FlowOCF − Capex
$9.1M
$-1.9M
FCF MarginFCF / Revenue
7.6%
-2.8%
Capex IntensityCapex / Revenue
0.1%
1.4%
Cash ConversionOCF / Net Profit
1.53×
TTM Free Cash FlowTrailing 4 quarters
$14.8M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIPO
HIPO
INGN
INGN
Q4 25
$9.2M
$-943.0K
Q3 25
$16.9M
$2.2M
Q2 25
$24.7M
$4.3M
Q1 25
$-35.6M
$-16.8M
Q4 24
$47.5M
$-3.0M
Q3 24
$46.8M
$7.0M
Q2 24
$-10.6M
$6.7M
Q1 24
$17.7M
$-4.7M
Free Cash Flow
HIPO
HIPO
INGN
INGN
Q4 25
$9.1M
$-1.9M
Q3 25
$16.8M
$1.6M
Q2 25
$24.6M
$3.7M
Q1 25
$-35.7M
$-17.1M
Q4 24
$47.2M
$-3.3M
Q3 24
$5.3M
Q2 24
$-10.7M
$6.6M
Q1 24
$17.6M
$-6.1M
FCF Margin
HIPO
HIPO
INGN
INGN
Q4 25
7.6%
-2.8%
Q3 25
13.9%
2.0%
Q2 25
21.0%
4.6%
Q1 25
-32.4%
-24.9%
Q4 24
46.3%
-5.0%
Q3 24
7.1%
Q2 24
-11.9%
8.9%
Q1 24
20.7%
-9.6%
Capex Intensity
HIPO
HIPO
INGN
INGN
Q4 25
0.1%
1.4%
Q3 25
0.1%
0.7%
Q2 25
0.1%
0.9%
Q1 25
0.1%
0.4%
Q4 24
0.3%
0.5%
Q3 24
0.0%
2.2%
Q2 24
0.1%
0.1%
Q1 24
0.1%
2.1%
Cash Conversion
HIPO
HIPO
INGN
INGN
Q4 25
1.53×
Q3 25
0.17×
Q2 25
19.00×
Q1 25
Q4 24
1.07×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIPO
HIPO

Segment breakdown not available.

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons